Blood pressure drugs linked to falls? new trial seeks answers

NCT ID NCT07099677

Recruiting now Knowledge-focused Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether three common blood pressure medications (beta-blockers, ACE inhibitors, and calcium channel blockers) affect balance and fall risk in adults newly diagnosed with high blood pressure. About 186 participants will be randomly assigned to one of the three drugs and tested at the start, 2 weeks, and 4 weeks. The goal is to see if any drug class increases fall risk, which could help doctors choose safer treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: beta-blocker, ACE inhibitor, calcium channel blocker
What this could lead to: If successful, this could help doctors choose blood pressure medications that are less likely to cause falls in older adults.
What could go wrong: This is a small, short-term study (4 weeks) in newly diagnosed patients, so results may not apply to long-term use or older adults with other health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALL RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALL RISK FEAR OF FALLING HYPERTENSION POSTURAL BALANCE

Contacts and locations

Locations

Bolu Abant Izzet Baysal University, Izzet Baysal Training and Research Hospital
RECRUITING

Bolu, 14030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.